Showing results (291-300 of 465) with videos related to

Sort By:
Pageof 47
The Lancet. Rheumatology|January 30, 2024
Comparison between adalimumab introduction and methotrexate dose escalation in patients with inadequately controlled psoriatic arthritis (CONTROL): a randomised, open-label, two-part, phase 4 studyLaura C Coates, William Tillett, Maria-Antonietta D'Agostino, et al.
Lancet (London, England)|October 5, 2015
Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trialLaura C Coates, Anna R Moverley, Lucy McParland, et al.
Annals of Internal Medicine|December 31, 2019
Disease-Modifying Effects of a Novel Cathepsin K Inhibitor in Osteoarthritis: A Randomized Controlled TrialPhilip G Conaghan, Michael A Bowes, Sarah R Kingsbury, et al.
BMJ Open|July 22, 2021
Peer mentorship to improve self-management of hip and knee osteoarthritis: a randomised feasibility trialAnna M Anderson, Elizabeth C Lavender, Esther Dusabe-Richards, et al.
Radiology|September 11, 2019
Statin Use and Knee Osteoarthritis Outcome Measures according to the Presence of Heberden Nodes: Results from the Osteoarthritis InitiativeArya Haj-Mirzaian, Bahram Mohajer, Ali Guermazi, et al.
Seminars in Arthritis and Rheumatism|March 14, 2025
Summary of findings tables for measurement property reviews: The evolution and application of OMERACT's summary of measurement properties (SOMP) TableDorcas Beaton, Maarten Boers, Clifton O Bingham, et al.
Rheumatology and Therapy|April 18, 2024
Exploring the Effects of Ixekizumab on Pain in Patients with Ankylosing Spondylitis Based on Objective Measures of Inflammation: Post Hoc Analysis from a Large Randomized Clinical TrialKurt de Vlam, Walter P Maksymowych, Gaia Gallo, et al.
Seminars in Arthritis and Rheumatism|March 30, 2021
Volumetric quantitative measurement of hip effusions by manual versus automated artificial intelligence techniques: An OMERACT preliminary validation studyJacob L Jaremko, Banafshe Felfeliyan, Abhilash Hareendranathan, et al.
Annals of the Rheumatic Diseases|April 28, 2010
Patients with RA in remission on TNF blockers: when and in whom can TNF blocker therapy be stopped?Benazir Saleem, Helen Keen, Vincent Goeb, et al.
Nature Reviews. Disease Primers|October 14, 2016
OsteoarthritisJohanne Martel-Pelletier, Andrew J Barr, Flavia M Cicuttini, et al.
Pageof 47